Although Alzheimer disease is not infectious by any common definition of the term, research over the past 20 years has confirmed long-standing speculation that the molecular mechanism driving neurodegeneration is fundamentally the same in Alzheimer disease and the prototypical infectious proteopathy—prion disease.
At the recent American Headache Society meeting, researchers detailed the manifold risks of opioid use in patients with migraine.
A new treatment for NMOSD has been found to reduce relapse, decrease re-hospitalizations, and hinder the need to treat acute attacks with corticosteroids and plasma exchange.
The genomic revolution has led to increasing opportunities to address complex neurodevelopmental conditions, taking a genetics-first approach.
Six months after delivering a healthy baby girl, a physician experiences intermittent blurred vision and tingling in her left leg. Her diagnosis might surprise you.
The latest advances in diagnosis and treatment are discussed in meeting presentations and recent studies and reviews.
MAST study results, remote electrical neuromodulation for acute treatment, and noninvasive vagus nerve stimulation are featured topics.
Because opioids have been shown to increase disability and reduce quality of life in patients with migraine, the search is on for effective alternative treatments.
Nearly one-third of persons with four or more migraine headache days per month have not received a diagnosis.
A promising alternative for patients who do not respond well to triptans or who wish to avoid pharmacotherapy.